Press Releases | Medtronic

Month Year

Email alerts

Mar 14, 2017

Medtronic Melody Transcatheter Pulmonary Valve First of Its Kind to Receive FDA Approval for Implantation in Failed Surgical Pulmonary Heart Valves

Newly Approved Indication in U.S. Expands Treatment Options to More Patients with Congenital Heart Disease

DUBLIN - March 14, 2017 - Medtronic plc (NYSE: MDT) today announced that its Melody(TM)Transcatheter Pulmonary Valve (TPV) received approval from the United States Food and Drug Administration...
Mar 13, 2017

Medtronic Receives FDA Clearance for Reveal LINQ(TM) Insertable Cardiac Monitor (ICM) with TruRhythm(TM) Detection

Device Delivers Improved Accuracy and Streamlined Data for Clinicians

DUBLIN - Mar. 13, 2017 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its Reveal LINQ(TM) Insertable Cardiac Monitor (ICM) with...
Mar 11, 2017

Medtronic Chairman and CEO Omar Ishrak to Speak at Bernstein Strategic Decisions Conference

DUBLIN - May 11, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Bernstein 33rd Annual Strategic Decisions Conference on...
Mar 10, 2017

Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2017

DUBLIN - Mar. 10, 2017 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2017 fourth quarter cash dividend of $0.43 per ordinary share, representing a 13 percent...
Mar 10, 2017

Medtronic Announces Medicare Reimbursement for the First and Only Leadless Pacemaker Available for Use in the U.S.

CMS Approves Required Studies for the Micra® Transcatheter Pacing System (TPS), the World's Smallest Pacemaker

DUBLIN - Mar. 10, 2017 - Medtronic plc (NYSE: MDT) today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has approved coverage for the Micra® Transcatheter Pacing System...
Mar 9, 2017

Medtronic Launches Below-The-Knee Clinical Study in Europe for Treatment of PAD Using New Drug-Coated Balloon Technology

First Procedure in Prospective, Randomized, Multi-Center Study Performed at Maria Cecilia Hospital in Italy

DUBLIN - Mar. 9, 2017 - Medtronic plc (NYSE: MDT) today announced the launch of the IN.PACT(TM) BTK study to evaluate the effectiveness of using a drug-coated balloon (DCB) in patients with...
Mar 3, 2017

Medtronic EVP & CFO Karen L. Parkhill to Speak at Barclays Healthcare Conference

DUBLIN - Mar. 3, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Barclays Global Healthcare Conference on Wednesday, March 15,...
Feb 27, 2017

Medtronic EVP & RTG President Geoffrey S. Martha to Speak at Cowen Healthcare Conference

DUBLIN - Feb. 27, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 37th Annual Cowen and Company Healthcare Conference on...
Feb 27, 2017

New Analysis of Reverse Trial Shows Medtronic CRT Devices Cost-Effective, While Helping Patients with Mild Heart Failure Live Longer

JACC: HF Study Showcases Economic Value of Earlier Patient Access to Cardiac Resynchronization Therapy

DUBLIN - Feb. 27, 2017 - Medtronic plc (NYSE:MDT) today announced an economic analysis of five-year data showing that patients with mild heart failure who get cardiac resynchronization therapy...
Feb 24, 2017

Medtronic Receives CE Mark for Its Next Generation Cardiac Resynchronization Therapy-Pacemakers

Suite of Smart Heart Failure Devices Offers More-Effective Pacing, Expanded MRI Access

DUBLIN - Feb. 24, 2017 - Medtronic plc (NYSE:MDT) today announced that it has received CE (Conformité Européenne) Mark for a suite of quadripolar cardiac resynchronization therapy pacemakers...

Show per page